Case report: Circulating tumor DNA technology displays temporal and spatial heterogeneity in Waldenström macroglobulinemia during treatment with BTK inhibitors

Background: Waldenström macroglobulinemia (WM) is a rare subtype of B-cell lymphoma. Rituximab-based combination therapy and Bruton’s tyrosine kinase (BTK) inhibitors have greatly improved the prognosis of WM. Despite the high response rate and good tolerance of BTK inhibitors in treatment of WM, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jingjing, Zhu, Xinyu, Xie, Fengyang, Ding, Yi, Lu, Huina, Dong, Yan, Li, Ping, Fu, Jianfei, Liang, Aibin, Zeng, Yu, Xiu, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154527/
https://www.ncbi.nlm.nih.gov/pubmed/37151353
http://dx.doi.org/10.3389/pore.2023.1611070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154527/
https://www.ncbi.nlm.nih.gov/pubmed/37151353
http://dx.doi.org/10.3389/pore.2023.1611070

Ejemplares similares